75 results
Page 3 of 4
6-K
EX-99.1
x2t605w3z7p3deeb
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.2
e7xvlt lz
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
wpo3qedf1sg0
23 Aug 21
Current report (foreign)
8:16am
424B3
b90xdu
14 Jul 21
Prospectus supplement
4:06pm
F-3
g5y7m0sixe768 o7d
2 Jul 21
Shelf registration (foreign)
7:36am
F-3
EX-10.1
kqb6n2yw
2 Jul 21
Shelf registration (foreign)
7:36am
F-3ASR
otlky4jd5y4clgs1
1 Jul 21
Automatic shelf registration (foreign)
4:32pm
20-F
EX-4.8
0koi2c9
2 Apr 21
Annual report (foreign)
8:10am
20-F
zosmjxpyp htt
2 Apr 21
Annual report (foreign)
8:10am
20-F
EX-2.5
95gajj4
2 Apr 21
Annual report (foreign)
8:10am
6-K
EX-99.2
nthm3
18 Mar 21
Legend Biotech Corporation 6-K
7:00am
6-K
EX-99.1
nupcj4
18 Mar 21
Legend Biotech Corporation 6-K
7:00am
6-K
EX-99.1
dgi 5lp4wk
23 Nov 20
Legend Biotech Announces New Appointment to the Board of Directors
7:19am
6-K
EX-99.1
vj0wgiy xa3
16 Nov 20
Legend Biotech Reports Third Quarter 2020 Financial Results
7:07am
6-K
EX-99.1
jc1u781058pa5 qurvq
9 Nov 20
Legend Biotech Announces Leadership Transition
8:06am
6-K
bcblyzym g4rg44
21 Sep 20
Legend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEO
7:36am
6-K
EX-99.1
6n494ak
21 Sep 20
Legend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEO
7:36am
S-8 POS
EX-10.2
vctz3v d3d7l4drt0d
4 Sep 20
Registration of securities for employees (post-effective amendment)
4:19pm
S-8
EX-10.2
1r4x1qwwvzkzg
26 Jun 20
Registration of securities for employees
4:11pm
S-8
EX-4.3
h004d5w
26 Jun 20
Registration of securities for employees
4:11pm